Menu
- Microbiology
- Sexual Health
- Pregnancy & Fertility
- Point of Care Tests
- Autoimmune
- Coagulation & Haematology
- Drugs of Abuse
- Clinical Chemistry
- Research Biochemistry
- Food Safety Tests
| Brand: | LDN |
| Product Code: | BA R-8800 |
Advantages:-
Cells derived form neuroendocrine tumours (e.g. pheochromcytoma) are known to produce catecholamines which are secreted
episodically via vesicles into the bloodstream.
But beside this a small portion of the catecholamines is metabolized inside the cells to the corresponding catecholamines
metabolites – namely metanephrine, normetanephrine and 3-methoxytyramine (3-MT) – which are secreted at low levels
continuously into the bloodstream.
3-methoxytyramine is a metabolite of the neurotransmitter Dopamine formed by the introduction of a methyl group to dopamine by
the enzyme catechol-O-methyl transferase (COMT).
The measurement of 3-MT allows the detection of dopamine-producing tumours: For example a substantial number of patients
with head and neck paragangliomas (HNPGL) have biochemically active tumours and only display increased excretion of 3-methoxytyramine, but not of other catecholamines or their metabolites.
The combined levels of free metanephrine/normetanephrine and free 3-MT in plasma indicate a higher number of biochemically
active HNPGLs than the 24-h urinary excretion rates of these markers.
In addition 3-MT acts as a neuromodulator and can also induce behavioral effects involved in movement control in a dopamineindependent manner. Most of these effects are mediated by the trace amine associated receptor 1 (TAAR1) which in turn is
involved in abnormal dopaminergic transmission, such as Parkinson's disease, dyskinesia and schizophrenia.
th head-and-neck paragangliomas (HNPGL) have biochemically active tumors and only display increased excretion of 3-
methoxytyramine, but not of other catecholamines or their metabolites.
The combined levels of free metanephrine/normetanephrine and free 3-MT in plasma indicate a higher number of biochemically
active HNPGLs than the 24-h urinary excretion rates of these markers.
In addition 3-MT acts as a neuromodulator and can also induce behavioral effects involved in movement control in a dopamineindependent manner. Most of these effects are mediated by the trace amine associated receptor 1 (TAAR1) which in turn is involved in abnormal dopaminergic transmission, such as Parkinson's disease, dyskinesia and schizophrenia.